Uveitis-related Cystoid Macular Edema

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2019-03-27
Clinical Trial Update: The LIMO Study, Lucentis for Treatment of Uveitic Patients With Refractory Cystoid Macular Oedema [Phase 2]
Phase 2 clinical trial update for Lucentis (ranibizumab) in uveitic cystoid macular edema; study completed.